Watch Live

Tweet TWEET

Clavis Pharma ASA : Clavis Pharma ASA : Information from the Election Committee

    Clavis Pharma ASA : Clavis Pharma ASA : Information from the Election
                                  Committee

Oslo, Norway, 14 June 2013

Clavis Pharma ASA (OSE: CLAVIS), reference is made to the announcement of 24
May 2013 regarding Clavis Pharma ASA's Annual General Meeting 2013, and agenda
item 6 and 8: Remuneration for the Board of Directors and Election of Board
members. Please find attached additional information from the Election
Committee in regards to these agenda items.



Contact:

Gunnar Manum

Acting CEO and CFO

+47 24 11 09 71

+47 95 17 91 90 (mob)

gunnar.manum@clavispharma.com

This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.
Clavis Pharma ASA - additional information from Election Committee

------------------------------------------------------------------------------

This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
the
information contained therein.

Source: Clavis Pharma ASA via Thomson Reuters ONE
HUG#1709578